These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28951413)

  • 21. Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
    Hocking JS; Temple-Smith M; Guy R; Donovan B; Braat S; Law M; Gunn J; Regan D; Vaisey A; Bulfone L; Kaldor J; Fairley CK; Low N;
    Lancet; 2018 Oct; 392(10156):1413-1422. PubMed ID: 30343857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of the COM-B model to barriers and facilitators to chlamydia testing in general practice for young people and primary care practitioners: a systematic review.
    McDonagh LK; Saunders JM; Cassell J; Curtis T; Bastaki H; Hartney T; Rait G
    Implement Sci; 2018 Oct; 13(1):130. PubMed ID: 30348165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barriers to opportunistic chlamydia testing in primary care.
    McNulty CA; Freeman E; Bowen J; Shefras J; Fenton KA
    Br J Gen Pract; 2004 Jul; 54(504):508-14. PubMed ID: 15239912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary care integration of sexual and reproductive health services for chlamydia testing across WHO-Europe: a systematic review.
    Quezada-Yamamoto H; Dubois E; Mastellos N; Rawaf S
    BMJ Open; 2019 Oct; 9(10):e031644. PubMed ID: 31628129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study.
    Natoli L; Guy RJ; Shephard M; Whiley D; Tabrizi SN; Ward J; Regan DG; Badman SG; Anderson DA; Kaldor J; Maher L;
    BMJ Open; 2015 Apr; 5(4):e006922. PubMed ID: 25922100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contribution of qualitative research in designing a complex intervention for secondary prevention of coronary heart disease in two different healthcare systems.
    Corrrigan M; Cupples ME; Smith SM; Byrne M; Leathem CS; Clerkin P; Murphy AW
    BMC Health Serv Res; 2006 Jul; 6():90. PubMed ID: 16848896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Obstacles to effective treatment of depression. A general practitioners' postal survey in the north-west region of France].
    Mercier A; Kerhuel N; Stalnikiewitz B; Aulanier S; Boulnois C; Becret F; Czernichow P
    Encephale; 2010 Jun; 36 Suppl 2():D73-82. PubMed ID: 20513464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlamydia screening in England: a qualitative study of the narrative behind the policy.
    Sheringham J; Baraitser P; Simms I; Hart G; Raine R
    BMC Public Health; 2012 Apr; 12():317. PubMed ID: 22545922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incentive payments to general practitioners aimed at increasing opportunistic testing of young women for chlamydia: a pilot cluster randomised controlled trial.
    Bilardi JE; Fairley CK; Temple-Smith MJ; Pirotta MV; McNamee KM; Bourke S; Gurrin LC; Hellard M; Sanci LA; Wills MJ; Walker J; Chen MY; Hocking JS
    BMC Public Health; 2010 Feb; 10():70. PubMed ID: 20158918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do Australian general practitioners believe practice nurses can take a role in chlamydia testing? A qualitative study of attitudes and opinions.
    Lorch R; Hocking J; Guy R; Vaisey A; Wood A; Donovan B; Fairley C; Gunn J; Kaldor J; Temple-Smith M;
    BMC Infect Dis; 2015 Jan; 15():31. PubMed ID: 25885341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlamyweb Study I: rationale, design and acceptability of an internet-based chlamydia testing intervention.
    Lydié N; de Barbeyrac B; Bluzat L; Le Roy C; Kersaudy-Rahib D
    Sex Transm Infect; 2017 May; 93(3):179-187. PubMed ID: 28258251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study.
    Watkins C; Timm A; Gooberman-Hill R; Harvey I; Haines A; Donovan J
    Fam Pract; 2004 Dec; 21(6):661-9. PubMed ID: 15528289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "I Do Feel Like a Scientist at Times": A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting.
    Natoli L; Guy RJ; Shephard M; Causer L; Badman SG; Hengel B; Tangey A; Ward J; Coburn T; Anderson D; Kaldor J; Maher L;
    PLoS One; 2015; 10(12):e0145993. PubMed ID: 26713441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Willingness to offer chlamydia testing in general practice in New South Wales.
    Khan A; Hussain R; Plummer D; Minichiello V
    Aust N Z J Public Health; 2006 Jun; 30(3):226-30. PubMed ID: 16800198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Promoting primary care screening for Chlamydia trachomatis infection].
    Touboul Lundgren P; Detanne S; Dunais B; Bruno P; Bentz L; Khouri P; Lacroix Hugues V; Banide MCh; Pradier Ch
    Sante Publique; 2016; 28(3):299-308. PubMed ID: 27531428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What needs to change to increase chlamydia screening in general practice in Australia? The views of general practitioners.
    Hocking JS; Parker RM; Pavlin N; Fairley CK; Gunn JM
    BMC Public Health; 2008 Dec; 8():425. PubMed ID: 19115998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Who is coming back for more chlamydia testing within non-specialist health services and where do they go? England, 2013-2016.
    Harb AK; Town K; Callan E; Furegato M; Connor N; Dunbar JK
    Public Health; 2020 Mar; 180():136-140. PubMed ID: 31901574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An embedded longitudinal multi-faceted qualitative evaluation of a complex cluster randomized controlled trial aiming to reduce clinically important errors in medicines management in general practice.
    Cresswell KM; Sadler S; Rodgers S; Avery A; Cantrill J; Murray SA; Sheikh A;
    Trials; 2012 Jun; 13():78. PubMed ID: 22682095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formative mixed-method multicase study research to inform the development of a safer sex and healthy relationships intervention in further education (FE) settings: the SaFE Project.
    Young H; Turney C; White J; Lewis R; Bonell C
    BMJ Open; 2019 Jul; 9(7):e024692. PubMed ID: 31289053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing and screening for chlamydia in general practice: a cross-sectional analysis.
    Thomson A; Morgan S; Henderson K; Tapley A; Spike N; Scott J; van Driel M; Magin P
    Aust N Z J Public Health; 2014 Dec; 38(6):542-7. PubMed ID: 25308467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.